These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1744636)

  • 1. Does a retrovirally encoded superantigen cause multiple sclerosis?
    Rudge P
    J Neurol Neurosurg Psychiatry; 1991 Oct; 54(10):853-5. PubMed ID: 1744636
    [No Abstract]   [Full Text] [Related]  

  • 2. HTLV-I and neurological disease in South India.
    Richardson JH; Newell AL; Newman PK; Mani KS; Rangan G; Dalgleish AG
    Lancet; 1989 May; 1(8646):1079. PubMed ID: 2566026
    [No Abstract]   [Full Text] [Related]  

  • 3. Human T lymphotropic virus, type-I myelopathy: an immunopathologically mediated chronic progressive disease of the central nervous system.
    Jacobson S
    Curr Opin Neurol; 1995 Jun; 8(3):179-83. PubMed ID: 7551116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative HTLV-I serology in "undiagnosed" myelopathy in north west England and North Wales.
    Longson M; Blumhardt LD; Moore AP
    J Neurol Neurosurg Psychiatry; 1991 Feb; 54(2):185-6. PubMed ID: 2019850
    [No Abstract]   [Full Text] [Related]  

  • 5. Cell surface phenotype and human T lymphotropic virus type 1 antigen expression in 12 T cell lines derived from peripheral blood and cerebrospinal fluid of West Indian, Guyanese and African patients with tropical spastic paraparesis.
    Gessain A; Saal F; Giron ML; Lasneret J; Lagaye S; Gout O; De Thé G; Sigaux F; Peries J
    J Gen Virol; 1990 Feb; 71 ( Pt 2)():333-41. PubMed ID: 2307964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex vivo analysis of human T lymphotropic virus type 1-specific CD4+ cells by use of a major histocompatibility complex class II tetramer composed of a neurological disease-susceptibility allele and its immunodominant peptide.
    Nose H; Kubota R; Seth NP; Goon PK; Tanaka Y; Izumo S; Usuku K; Ohara Y; Wucherpfennig KW; Bangham CR; Osame M; Saito M
    J Infect Dis; 2007 Dec; 196(12):1761-72. PubMed ID: 18190256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human T lymphotropic virus type I (HTLV-I)-specific T helper cell responses from HTLV-I seronegative patients with chronic myelopathy and MS in Japan.
    Nishimura M; Jacobson S; Uchiyama T; Ohta M; Saida T
    Mult Scler; 1996 Feb; 1(4):200-3. PubMed ID: 9345434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tropical spastic paraparesis and HTLV-I myelopathy: clinical features and pathogenesis.
    Rodgers-Johnson PE; Ono SG; Asher DM; Gibbs CJ
    Res Publ Assoc Res Nerv Ment Dis; 1990; 68():117-30. PubMed ID: 2183307
    [No Abstract]   [Full Text] [Related]  

  • 9. HTLV-I positive spastic paraparesis in a temperate zone.
    Cartier-Rovirosa L; Mora C; Araya F; Castillo J; Verdugo R; Miller MA; Gajdusek DC; Gibbs CJ
    Lancet; 1989 Mar; 1(8637):556-7. PubMed ID: 2564088
    [No Abstract]   [Full Text] [Related]  

  • 10. Involvement of p38 MAPK signaling pathway in IFN-gamma and HTLV-I expression in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Fukushima N; Nishiura Y; Nakamura T; Yamada Y; Kohno S; Eguchi K
    J Neuroimmunol; 2005 Feb; 159(1-2):196-202. PubMed ID: 15652420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HTLV-I and neurological disease: from tropical spastic paraparesis to HTLV-I-associated myelopathy: what next?
    Njamnshi AK; Kuate CT; Muna WF
    Neurologist; 2007 Nov; 13(6):391. PubMed ID: 18090720
    [No Abstract]   [Full Text] [Related]  

  • 12. Low prevalence of HTLV-1 antibodies in the serum of patients with tropical spastic paraplegia from the Ivory Coast.
    Hugon J; Vallat JM; Dumas M; Verdier M; Denis F; Akani F; Boa YF; Giordano C
    J Neurol Neurosurg Psychiatry; 1990 Mar; 53(3):269. PubMed ID: 2157820
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunophenotypic characterization of CSF B cells in virus-associated neuroinflammatory diseases.
    Enose-Akahata Y; Azodi S; Smith BR; Billioux BJ; Vellucci A; Ngouth N; Tanaka Y; Ohayon J; Cortese I; Nath A; Jacobson S
    PLoS Pathog; 2018 Apr; 14(4):e1007042. PubMed ID: 29709026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High IFN-γ/IL-10 expression ratio and increased frequency of persistent human T-cell lymphotropic virus type 1-infected clones are associated with human T-cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis development.
    Espíndola OM; Oliveira LC; Ferreira PM; Leite AC; Lima MA; Andrada-Serpa MJ
    Intervirology; 2015; 58(2):106-14. PubMed ID: 25833232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
    Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
    J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease.
    Jacobson S
    J Infect Dis; 2002 Dec; 186 Suppl 2():S187-92. PubMed ID: 12424696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load.
    Nagai M; Kubota R; Greten TF; Schneck JP; Leist TP; Jacobson S
    J Infect Dis; 2001 Jan; 183(2):197-205. PubMed ID: 11120926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The distinction blurs between an autoimmune versus microbial hypothesis in multiple sclerosis.
    Hafler DA
    J Clin Invest; 1999 Sep; 104(5):527-9. PubMed ID: 10487765
    [No Abstract]   [Full Text] [Related]  

  • 19. Human T cell lymphotropic virus (HTLV) type-1-specific CD8+ T cells: frequency and immunodominance hierarchy.
    Goon PK; Biancardi A; Fast N; Igakura T; Hanon E; Mosley AJ; Asquith B; Gould KG; Marshall S; Taylor GP; Bangham CR
    J Infect Dis; 2004 Jun; 189(12):2294-8. PubMed ID: 15181578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic control and dynamics of the cellular immune response to the human T-cell leukaemia virus, HTLV-I.
    Bangham CR; Hall SE; Jeffery KJ; Vine AM; Witkover A; Nowak MA; Wodarz D; Usuku K; Osame M
    Philos Trans R Soc Lond B Biol Sci; 1999 Apr; 354(1384):691-700. PubMed ID: 10365395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.